Lucy Lu
2019 - AVENUE THERAPEUTICS
In 2019, Lucy Lu earned a total compensation of $639.8K as Chief Executive Officer at AVENUE THERAPEUTICS, a 60% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $209,528 |
|---|---|
| Salary | $419,055 |
| Other | $11,200 |
| Total | $639,783 |
Lu received $419.1K in salary, accounting for 65% of the total pay in 2019.
Lu also received $209.5K in non-equity incentive plan and $11.2K in other compensation.
Rankings
In 2019, Lucy Lu's compensation ranked 11,007th out of 13,971 executives tracked by ExecPay. In other words, Lu earned more than 21.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,007 out of 13,971 | 21st |
Division Manufacturing | 4,454 out of 5,695 | 22nd |
Major group Chemicals And Allied Products | 1,741 out of 2,194 | 21st |
Industry group Drugs | 1,495 out of 1,880 | 21st |
Industry Pharmaceutical Preparations | 1,106 out of 1,392 | 21st |
Source: SEC filing on April 29, 2020.
Lu's colleagues
We found one more compensation record of an executive who worked with Lucy Lu at AVENUE THERAPEUTICS in 2019.
2019
Joseph Vazzano
AVENUE THERAPEUTICS
Chief Financial Officer
News
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019